Login
← Go Back
Nectar Lifesciences
NECLIFE · Pharma > Pharmaceuticals & Drugs · Chairman: Sanjiv Goyal · MD: Sanjiv Goyal · Listing date: July 19, 2005 · Employees: 1693 · Chandigarh · http://www.neclife.com
Stock Price vs Company Growth
1d
1.4%
1w
4.8%
1m
2.5%
3m
4.1%
6m
2.5%
1y
63.5%
5y
16.2%
10y
0.8%
all
4.2%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 31.3 1.4%
26.2
38
Company Overview
Sales
1,686 Cr
Growth: 3.1%
Profit after Tax
4.99 Cr
Growth: -38.2%
Small Cap
703 Cr
P/E: 136.3x
Industry P/E: 35.4x
Fundamentals
Sales (Cr) ₹ 1,686
Growth 3.1%
EBITDA 9.1%
P/S 0.4x
Dividend 0.0%
P/E 136.3x
Book Value ₹ 1
PEG Ratio 43.4x
ROE 22.3%
P/B N/A
Shareholding Pattern
Institutions
Nsr Direct Pe Mauritius Llc
14.59 %
Ingain Traders, Llc
1.34 %
Iepf
0.02 %
Promoters
Sanjiv Goyal
31.33 %
Sanjiv (Huf)
24.47 %
Others
Increase    Decrease    No change
Company Profile Detailed
The company has developed fully integrated sustainable production systems to manufacture high quality Cephalosporin intermediates, - Active Pharmaceuticals ingredients (APIs) and Finished Dosage Formulations (FDF or Formulations) to meet the diverse requirements of its customer base in India and over many countries worldwide.
Investors (16)
iepf
sanjiv.h...
sanjeev....
Followers (2)
bhaskar6
sanjayda...